ArticleProceedings of the National Academy of Sciences of the United States of America2026
Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer.
Emmanuel B Asiedu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.